SCHEMBL2801655

SCHEMBL2801655

Cc1ccc(F)c(Nc2c(C(=O)N3CCC(c4ccccc4)CC3)cnc3c(C(=O)O)cnn23)c1

nearest known ligand 0.41

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.41
SPR P35270 3/20 0.40
EGLN1 Q9GZT9 1/20 0.40
F11 P03951 1/20 0.39
KMT2A Q03164 2/20 0.39
KDM4E B2RXH2 1/20 0.39
MEN1 O00255 1/20 0.39
LMNA P02545 1/20 0.39
TP53 P04637 3/20 0.38
IDO1 P14902 2/20 0.38
FASN P49327 1/20 0.38
PDE4B Q07343 1/20 0.38
L3MBTL1 Q9Y468 1/20 0.38
NPC1 O15118 1/20 0.37
MAPT P10636 1/20 0.37
RAB9A P51151 1/20 0.37
SMN1; SMN2 Q16637 1/20 0.37
AVPR1A P37288 1/20 0.37
CCR3 P51677 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2799735 0.94 FASN (0.40) ALDH1A1EGLN1LMNATP53FASN
SCHEMBL2801212 0.92 DHODH (0.37) ALDH1A1SPREGLN1KDM4ELMNA
SCHEMBL2800543 0.92 EGLN1 (0.37) ALDH1A1SPREGLN1KMT2AKDM4E
SCHEMBL2802498 0.92 ALDH1A1 (0.40) ALDH1A1SPREGLN1F11KMT2A
SCHEMBL2799436 0.91 TP53 (0.44) ALDH1A1SPRF11KMT2ALMNA
SCHEMBL2800966 0.91 FASN (0.40) ALDH1A1EGLN1KDM4ETP53FASN
SCHEMBL2800415 0.90 SIRT5 (0.43) ALDH1A1SPREGLN1F11LMNA
SCHEMBL2802567 0.89 EGLN1 (0.38) ALDH1A1SPREGLN1F11KMT2A
SCHEMBL2800842 0.89 ALDH1A1 (0.38) ALDH1A1SPREGLN1F11KMT2A
SCHEMBL2800090 0.88 ALDH1A1 (0.42) ALDH1A1SPREGLN1F11KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2206714-B1 AGENT FOR PREVENTION AND/OR TREATMENT OF SKIN DISEASES KYOWA HAKKO KIRIN CO LTD (JP) 2015-01-21 EP disclosed
US-8729264-B2 Agent for prevention and/or treatment of skin diseases KYOWA HAKKO KIRIN CO., LTD. (JP) 2014-05-20 US disclosed
US-20100256134-A1 AGENT FOR PREVENTION AND/OR TREATMENT OF SKIN DISEASES KYOWA HAKKO KIRIN CO., LTD. (JP) 2010-10-07 US disclosed
EP-2206714-A1 AGENT FOR PREVENTION AND/OR TREATMENT OF SKIN DISEASES Kyowa Hakko Kirin Co., Ltd. (JP) 2010-07-14 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100256134-A1 AGENT FOR PREVENTION AND/OR TREATMENT OF SKIN DISEASES TYR, CUTA, SERPINB1 ALDH1A1 243/4885SPR 2955/4885EGLN1 1967/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.